Mabpharm Limited

HKEX:2181.HK

0.305 (HKD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017
Operating Activities:
Net Income -209.356-210.819-291.744-184.632-202.529-152.593-47.706
Depreciation & Amortization 60.69551.54943.87724.39722.19811.71610.08
Deferred Income Tax 1.45206.67331.925-15.693.2660
Stock Based Compensation 13.4699.78212.2412.40613.8445.4450
Change In Working Capital 181.70581.99629.035-25.81141.78865.943-33.053
Accounts Receivables -10.318-8.857-0.7930000
Inventory -1.24-47.586-19.793-11.2265.0557.929-33.38
Accounts Payables 10.3188.8570.7930000
Other Working Capital 182.945129.58248.828-14.58536.73358.0140.327
Other Non Cash Items 9.42710.6070.449-5.5163.774.3495.557
Operating Cash Flow 57.392-56.885-199.47-147.231-136.619-61.874-65.122
Investing Activities:
Investments In Property Plant And Equipment -19.042-125.128-148.666-197.243-113.569-90.897-13.129
Acquisitions Net 00012.896000
Purchases Of Investments 0-150-45.012-180.67400
Sales Maturities Of Investments 15.38600224.35000
Other Investing Activites 0.15135.173-30.752161.008-118.8478.191-0.468
Investing Cash Flow -3.505-104.955-179.418155.999-413.09-82.706-13.597
Financing Activities:
Debt Repayment -2.25-8.166-15.349-63.086-136.985-30-0.281
Common Stock Issued 00001,033.268410.4840
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -26.003120.428-2.432-17.39226.475-153.66517.178
Financing Cash Flow 85.597112.262-17.781-80.478922.758256.81916.897
Other Information:
Effect Of Forex Changes On Cash 0.2931.59-6.621-32.16417.476-2.427-2.337
Net Change In Cash 139.777-47.988-403.29-103.874390.525121.752-33.23
Cash At End Of Period 173.34533.56881.556484.846588.72198.19576.443